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ABSTRACT Cytoplasmic dynein is a multisubunit, mi-
crotubule-associated, mechanochemical enzyme that has been
identified as a retrograde transporter of various membranous
organelles. Dynactin, an additional multisubunit complex, is
required for efficient dynein-mediated transport of vesicles in
vitro. Recently, we showed that three genes defined by a group
of phenotypically identical mutants of the filamentous fungus
Neurospora crassa encode proteins that are apparent subunits
of either cytoplasmic dynein or dynactin. These mutants,
designated ropy (ro), display abnormal hyphal growth and are
defective in nuclear distribution. We propose that mutations
in other genes encoding dynein/dynactin subunits are likely to
result in a ropy phenotype and have devised a genetic screen
for the isolation of additional ro mutants. Cytoplasmic dy-
nein/dynactin is the largest and most complex of the cyto-
plasmic motor proteins, and the genetic system described here
is unique in its potentiality for identifying mutations in
undefined genes encoding dynein/dynactin subunits or regu-
lators. We used this screen to isolate > 1000 ro mutants, which
were found to define 23 complementation groups. Unexpect-
edly, interallelic complementation was observed with some
allele pairs of ro-1 and ro-3, which are predicted to encode the
largest subunits of cytoplasmic dynein and dynactin, respec-
tively. The results suggest that the Rol and Ro3 polypeptides
may consist of multiple, functionally independent domains. In
addition, -10% of all newly isolated ro mutants display
unlinked noncomplementation with two or more of the mu-
tants that define the 23 complementation groups. The fre-
quent appearance of ro mutants showing noncomplementa-
tion with multiple ro mutants having unlinked mutations
suggests that nuclear distribution in filamentous fungi is a
process that is easily disrupted by affecting either dosage or
activity of cytoplasmic dynein, dynactin, and perhaps other
cytoskeletal proteins or regulators.
Cytoplasmic dynein is a microtubule-associated motor enzyme
that has been implicated in a number of intracellular, micro-
tubule-dependent transport processes, including retrograde
axonal transport (1). In addition, cytoplasmic dynein plays a
role in mitotic spindle formation in mammalian cells, and in
Saccharomyces cerevisiae it participates in anaphase chromo-
some separation (2, 3). Dynein also is required for nuclear
migration in S. cerevisiae and nuclear distribution in the
filamentous fungi Aspergillus nidulans and Neurospora crassa
(4-7).
Cytoplasmic dynein, the largest and most complex of the
cytoplasmic motor proteins, is composed of two identical
heavy chains ("500 kDa), three intermediate chains ("70
kDa), and four light chains (53-59 kDa) (for review, see ref.
8). In addition, a multisubunit complex known as dynactin is
required for efficient dynein-mediated transport of vesicles in
vitro (9, 10). The dynactin complex consists of at least nine
different subunits, which include pl5oGlued (the largest sub-
unit) and the actin-related protein Arpl (the most abundant
subunit) (9-12).
Mutants defective in cytoplasmic dynein/dynactin have
been isolated in a number of organisms. The gene encoding
pl5OGlued was first identified in Drosophila (13-15). Flies
homozygous for recessive Glued mutations exhibit an embry-
onic lethal phenotype, and flies heterozygous for dominant
Glued alleles are defective in eye development and neural
connections between the eye and optic lobe (13, 14). The
isolation of S. cerevisiae genes encoding cytoplasmic dynein
heavy chain and Arpl allowed construction of dynein and
dynactin mutants, both of which are viable but defective in
nuclear migration (6, 7, 16, 17). Nuclear distribution (nud)
mutants have been isolated inA. nidulans, and one of the nud
genes, nudA4, encodes cytoplasmic dynein heavy chain (4).
In N. crassa, mutations at eight different loci define a group
of phenotypically identical mutants known as ropy (ro), which
are defective in hyphal growth and nuclear distribution (5, 18).
DNA sequence analysis of three of these genes, ro-1, ro-3, and
ro-4, revealed that they encode cytoplasmic dynein heavy
chain, pl5OGlued, and Arpl, respectively (5). These observa-
tions led us to predict that mutations in other genes encoding
subunits of cytoplasmic dynein or dynactin will also result in a
ropy phenotype. Therefore, a large-scale screen for ro mutants
of N. crassa may allow for the first time the identification of all
nonredundant genes encoding subunits or specific regulators
of cytoplasmic dynein and dynactin, and possibly of other genes
that are not required for dynein/dynactin activity but are
required for nuclear movement. Previously, we showed that ro
mutants can be readily isolated as partial suppressors of cot-1,
a gene encoding a serine/threonine protein kinase required
for hyphal elongation (5, 19). In this paper, we report the
isolation of >1000 ro mutants and the identification of 23 ro
complementation groups. Unexpectedly, -10% of all the
newly isolated ro mutants failed to complement two or more
ro mutants defining unlinked loci. The high frequency of ro
mutants displaying such unlinked noncomplementation may
reflect the complex subunit composition of cytoplasmic dynein
and dynactin and the need for coordinated activities of dynein
motors and other proteins for proper distribution of nuclei
within hyphae.
MATERIALS AND METHODS
Strains, Genetic Techniques, and Media. N. crassa strains
were obtained from the Fungal Genetics Stock Center (FGSC;
Department of Microbiology, University of Kansas Medical
Center, Kansas City). The ro mutants used in this study were
ro-l(B15) (FGSC no. 146), ro-2(B20) (FGSC no. 44), ro-3
(R2354) (FGSC no. 43), ro-4(P904) (FGSC no. 1669), ro-6
(R2431) (FGSC no. 3627), ro-7(P997) (FGSC no. 3322),
ro-10(AR7) (FGSC no. 3619), and ro-11(P3053) (FGSC no.
Abbreviations: FGSC, Fungal Genetics Stock Center; DAPI, 4',6-
diamidino-2-phenylindole.
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3911). The wild-type N. crassa strain was 74-OR23-1A (FGSC
no. 987), and a cot-l(C102t); his-3 strain was constructed and
used to isolate ro mutants as partial suppressors of cot-i (see
below). Crosses for mapping and strain construction and the
formation of heterokaryons for complementation analysis
were done using standard procedures (20). Media and growth
conditions were as described (20).
Isolation of ro Mutants and Complementation Analysis.
The isolation of ro mutants by screening for partial suppressors
of cot-I has been described (5). Briefly, spontaneous ro
mutations were identified as cot-i suppressors by plating -2 x
105 conidia of a temperature-sensitive cot-i mutant on sucrose-
supplemented minimal medium and incubating at 37°C for 3-7
days. cot-I conidia germinate under these conditions and
produce colonies that are -0.1 mm in diameter, whereas cot-i
mutants containing ro mutations produce colonies that are 1-5
mm in diameter. Newly isolated ro; cot-i strains were trans-
ferred to a fresh medium and incubated at 25°C. Each of the
ro; cot-i mutants was single colony purified three times. ro;
cot-i mutants that reverted rapidly to wild-type growth were
not used for complementation analysis.
Heterokaryons were formed between various ro mutants to
determine the number of complementation groups (20). A
trp-4 marker was crossed into each of the eight ro strains
obtained from the FGSC. These strains were used to make
forced heterokaryons with each of the newly isolated ro; cot-i;
his-3 strains by coinoculating on a minimal medium lacking
tryptophan and histidine. Because cot-I (C102t) is a temper-
ature-sensitive mutation that has no detectable effect on
growth morphology at the permissive temperature (25'C), all
complementation tests were conducted at 25'C. The ro mu-
tants have curled hyphae; the formation of straight, rapidly
extending hyphae was taken to indicate complementation
while retention of curled hyphal growth was taken to indicate
the lack of complementation. All of the ro mutations from the
FGSC were found to be recessive except ro-6, which is semi-
dominant in heterokaryons and could not be used in the
complementation analysis. Most of the newly isolated ro
mutants (70%) could be assigned to a complementation group
defined by one of the seven ro mutants obtained from the
FGSC (Table 1). The remaining ro mutants were sorted into
complementation groups by coinoculating pairs of mutants on
histidine-supplemented media and incubating at 25°C. Al-
though these ro mutants lack nutritional markers for "forcing"
formation of heterokaryons, strains containing ro mutations
have highly restricted growth rates so that positive comple-
mentation tests could be scored unambiguously on the basis of
presence of straight, rapidly extending hyphae.
Microscopic Examination of ro Mutants. Hyphal morphol-
ogies of wild-type and ro mutants were examined by inoculat-
ing sucrose minimal agar medium with conidia and incubating
plates at the designated temperature for 2 days. Pictures were
taken with Kodak TMAX 100 or TMAX 400 film (Eastman
Kodak Company, Rochester, NY) on an Olympus (New Hyde
Park, NY) binocular dissection microscope at 7x magnifica-
tion with transmitted light.
Nuclear distribution was examined by staining hyphae with
the DNA-specific dye 4',6-diamidino-2-phenylindole (DAPI).
Sterile dialysis membranes [1 cm x 1 cm; CELLU-SEP Ti
membrane, 4000-6000 Mr cut off, Membrane Filtration Prod-
ucts (San Antonio, TX)] were placed on an agar surface and
100 conidia were spread on each membrane; the plates were
then incubated at 25'C for 8 hr. Membranes with attached
hyphae were quick frozen in liquid N2, treated for 10 min with
fixing solution (3.7% formaldehyde in PBS), rinsed for 30 min
with wash solution (PBS) containing 0.5 ,ug/ml DAPI, and
then soaked in wash solution without DAPI for 30 min. A
membrane containing hyphal material was placed on a slide
and a coverslip anchored with Vaseline was then pressed to the
slide. Pictures were taken using TMAX 400 film with an
Table 1. Complementation groups of ro mutants
C.G. Defining allele* No. of mutantst No. of screent
1 ro-l(B15) 401 24
2 ro-2(B20) 49 13
3 ro-3(R2354) 103 19
4 ro-4(P904) 58 17
5 ro-7(P997) 61 17
6 ro-1O(AR7) 49 14
7 ro-11(P3053) 31 10
8 ro(B2) 149 22
9 ro(JT2) 2 1
10 ro-l(A59) 27 11
11 ro(L12) 41 12
12 ro(C52) 30 14
13 ro(K51) 13 9
14 ro(C18) 5 4
15 ro(C102) 5 5
16 ro-3(C115) 2 2
17 ro(C76) 9 3
18 ro(U3) 9 4
19 ro(I107) 2 2
20 ro(Jl) 1 1
21 ro(G42) 3 3
22 ro(P56) 3 3
23 ro(M76) 13 1
C.G., complementation group.
*Defining allele signifies the ro allele that was used as a tester strain
to define a given complementation group.
tTotal number of ro mutants that do not complement exclusively a
specific ro mutant tester strain.
tThe number of mutant screens, out of 24 independent screens, in
which a given complementation group was identified.
Olympus microscope using a SPlan Apo 60X oil objective and
differential interference contrast optics. The sample was illu-
minated with UV light to view the DAPI stain.
RESULTS
Isolation of ro Mutants and Complementation Analysis.
Our finding that three ro genes encode putative subunits of
cytoplasmic dynein or dynactin led us to conduct a large-scale
screen for ro mutants that may define additional genes re-
quired for cytoplasmic dynein/dynactin function and luclear
distribution. We showed previously that in the absence of Cotl
kinase activity, N. crassa forms small colonies ("0.1 mm in
diameter) consisting of masses of spheres with many short
hyphal tips while ro; cot-i double mutants form slightly larger
colonies (1-5 mm in diameter) that are easily distinguished
from cot-i colonies (5). The mechanism by which ro mutations
cause hyphal tips of a cot-i mutant to extend slowly is not
known.
Approximately 1500 ro mutants were isolated from 24
independent cot-I cultures by isolation of partial suppressors
of the cot-lts growth phenotype, and 1187 of these mutants
were assigned to complementation groups by heterokaryon
analysis (see Materials and Methods; Table 1). As a first step in
establishing the number of ro complementation groups, we
conducted complementation tests between the newly isolated
ro mutants and ro-1, -2, -3, -4, -7, -10, and -11 mutants that were
obtained from the FGSC. Approximately 30% of the ro
mutants complemented all seven of the initial tester strains,
and subsequent complementation tests established that these
mutants defined an additional 16 complementation groups
(Table 1). Typically, the number of loci defined by comple-
mentation groups would be determined by conducting a series
of pair-wise crosses between mutants defining each comple-
mentation group. However, most ro mutants are infertile when
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used as the female (21); therefore, we were unable to define
unambiguously the number of ro loci.
New ro Mutants and Nuclear Distribution. All ro mutants
from the FGSC are phenotypically identical, consisting of
curled hyphae with highly asymmetric nuclear distribution
relative to a wild-type strain (Fig. 1 A-D). To determine if the
curled hyphal growth characteristic of ro mutants always
coincides with defective nuclear distribution, we examined
nuclear distribution in the 16 tester strains defining each new
ro complementation group. Only 12 of the 16 new ro comple-
mentation groups had obvious nuclear distribution defects
(Fig. 1 E and F). Complementation groups 9, 15, 17, and 19
defined by ro(JT2), ro(C102), ro(C76), and ro(1107), respec-
tively, have a typical ro growth defect, without the character-
istic strong defect in nuclear distribution (Fig. lF). Numerous
mutants belonging to these four complementation groups were
identified and all were found to have nearly normal nuclear
distribution, suggesting that the mutants defining the four
groups do not contain "leaky" alleles of the typical ro genes.
These atypical ro mutants appear to have retained the ability
to move nuclei into growing hyphae; however, these nuclei are
not as evenly distributed as they are in a wild-type strain.
Complementation Between Alleles at ro-l and at ro-3.
Although the number of loci identified by the 16 new ro
FIG. 1. Curled hyphal growth and asymmetric nuclear distribution of ro mutants. Conidia from wild-type (A) and ro-3(R2354) (B) mutants were
inoculated onto sucrose minimal agar medium and incubated overnight at 25°C. Note the difference in hyphal morphologies of the wild-type strain
(A) and the ro-3(R2354) (B) mutant. Conidia from a wild-type strain (C) and ro-1(B15) (D) mutant were allowed to grow for 8 hr on filters placed
on sucrose minimal media at 25°C, and germinated conidia were stained with DAPI to visualize nuclei. Conidia from newly isolated ro mutants
ro(P56) (E) and ro(C76) (F) were incubated on sucrose minimal media for 8 hr and stained with DAPI to visualize nuclei. Note that nuclear
distribution in ro(C76) is not severely affected as it is in typical ro mutants. (A and B, bar = 500 ,um; C-F, bar = 20 ,um.)
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complementation groups cannot be determined unambigu-
ously by pair-wise crosses, we have isolated cosmid clones
containing the ro-i, -2, -3, -4, -7, -10, and -11 genes (5)
(unpublished data) and we have used these plasmids to
transform the defining mutant of each of the 16 new comple-
mentation groups. If a recessive ro mutant is not rescued by any
of the cloned ro genes, then it likely defines a new ro locus.
Most of the mutants defining the 16 new complementation
groups are not complemented by any of the seven ro clones.
However, the ro phenotype of complementation group 10
defined by ro(A59) was rescued by transformation with a
plasmid containing the ro-1 gene and complementation group
16 defined by ro(C115) was rescued by transformation with a
plasmid containing the ro-3 gene. This is an unexpected result
considering that ro(A59) and ro(C115) clearly complement
both ro-l(B15) and ro-3(R2354). Restriction endonuclease
digestion of plasmid DNA containing ro-i or ro-3 genes
established that digestion by restriction enzymes cutting only
within the respective genes eliminated rescue, while digestion
with restriction enzymes cutting outside of the respective genes
still allowed rescue. These results indicate that rescue is
dependent on ro-i or ro-3 sequences and likely results either
from extracopy suppression or by introduction of a wild-type
copy of the affected gene [i.e., ro(A59) and ro(C115) would
represent alleles of ro-i and ro-3, respectively]. To determine
if ro(A59) and ro(C115) are alleles of ro-1 and ro-3, respec-
tively, we mapped the ro(A59) and ro(C1 15) mutations relative
to the ro-1-linked markerspan-1 (<1%) and cot-1 (1-2%) and
the ro-3-linked markerpyr-4 (1-2%). In both cases, the ro(A59)
and ro(C115) mutations showed tight linkage (c1%) with ro-l-
and ro-3-linked markers, respectively. Additional mapping
studies of five other members of complementation group 10
and the remnaining member of complementation group 16,
ro(M144), also showed tight linkage with ro-l- and ro-3-linked
markers, respectively. Finally, neither ro(C115) nor ro(M144)
complement a ro-3 deletion strain, consistent with these two ro
mutations representing mutant alleles of ro-3. From these
results, we conclude that members of complementation group
10 represent alleles of ro-i that are capable of interallelic
complementation with the ro-l(B15) tester strain, and comple-
mentation group 16 represent alleles of ro-3 that are capable
of interallelic complementation with the ro-3(R2354) tester
strain.
Because complementation group 10 includes 27 ro-i mu-
tants isolated in 11 of the 24 screens (>5% of the ro-1 mutants
isolated), we expected that other ro-i mutants might also be
capable of interallelic complementation. To test this hypoth-
esis, pair-wise complementation tests were conducted between
24 ro-i mutants from complementation group 1 where each of
the ro-i mutants was isolated in an independent screen. As
shown in Table 2, six of the independent ro-1 mutants are
capable of complementing one or more of the ro-1 mutants.
Unlinked Noncomplementation. Most of the 1187 ro mu-
tants examined by complementation analysis were assigned
unambiguously to a single complementation group. However,
Table 2. Allelic complementation among select ro-1 mutants from
complementation group 1
ro-l(A5) ro-l(B1O) ro-l(C24) ro-1(E11) ro-1(039)
ro-l(B1O)
ro-l(C24) + +
ro-1(E11) - - -
ro-1(039) + - - +
ro-l(V22) + - - +
Complementation analysis was conducted by pair-wise formation of
heterokaryons. + and - signify complementation or noncomplemen-
tation, respectively, based on whether a heterokaryon grows as
straight, rapidly extending hyphae or grows as curled hyphae, respec-
tively.
121 of the ro mutants were found to not complement more than
one of the 23 tester strains. In many cases, these mutants fail
to complement two or more defining members of the first
seven complementation groups, which are known to map to
different loci, indicating that these represent examples of
unlinked noncomplementation. Five representative ro mutants
displaying unlinked noncomplementation are shown in Table
3. Many ro mutants show "allele-specific" noncomplementa-
tion. For example, mutants ro(A40), ro(B10), ro(C81), and
ro(E58) do not complement group 3 tester ro-3(R2354), but do
complement group 16 tester ro-3(C1 15) (Table 3). In addition,
all four of these mutants fail to complement group 1 tester
ro-1(B15), but ro(A40) and ro(C81) are able to complement
group 10 tester ro-l(A59) (Table 3).
Heterokaryons formed between the five representative ro
mutants displaying unlinked noncomplementation and the
complementation group testers 8-23 were not "forced" using
auxotrophic markers; it is possible that complex patterns of
unlinked noncomplementation observed with specific ro mu-
tants are due in some cases to the inability of a ro mutant to
form stable heterokaryons rather than an inability to restore
wild-type hyphal growth once a heterokaryon has formed.
Therefore, an auxotrophic marker (pan-i) was crossed into
each of the seven complementation group testers that did
complement one or more of the five representative ro mutants
displaying unlinked noncomplementation (shown in Table 3)
and the complementation tests repeated. In all cases, hetero-
karyons were successfully formed between the respective ro
mutants, and each of the resulting heterokaryons exhibited a
ro growth phenotype. The results indicate that complex un-
linked noncomplementation patterns are due to an inability to
restore wild-type hyphal growth rather than a general failure
to form heterokaryons.
DISCUSSION
Cytoplasmic dynein, along with the associated dynactin com-
plex, is the largest and most complex of the known mechano-
chemical enzymes operating in the cytoplasm (1, 8). Previ-
ously, we showed (5) that the N. crassa ro-i gene encodes the
heavy chain of cytoplasmic dynein, and that the ro-3 and ro-4
genes encode the dynactin subunits plSGlued and Arpi,
respectively. An exciting implication of these results is that
mutations in other genes encoding subunits or regulators of
cytoplasmic dynein and dynactin may also result in a ro
phenotype. In this study, we report the isolation and initial
characterization of 1187 ro mutants defining 23 complemen-
tation groups (Table 1). Twelve of these complementation
groups were identified in nine or more of the 24 independent
screens, while the remaining ro mutants defined an additional
11 complementation groups identified in 1-5 screens. The
number of loci defined by the 23 ro complementation groups
has not yet been determined because most ro mutants do not
function as the female in a cross (21). However, we are in the
process of determining the number of loci by restriction
fragment length mapping using cloned representatives of each
group (ro genes are easily cloned; ref. 5). The ro-i structural
gene consists of 4367 codons and, as expected, the ro-l(B15)
tester defines the largest complementation group, identified in
all 24 screens and representing >33% of all ro mutants. ro-10
is the smallest ro gene we have examined to date and 49 ro-10
mutants were identified from 14 of 24 screens (ro-10 is
nonessential for viability and encodes a 217-aa polypeptide;
unpublished data). The small size of ro-10 and the relatively
large number of screens from which ro-10 mutants were
identified suggests that our genetic screen is saturating for
those genes that do not present abnormally small genetic
targets. The relatively rare complementation groups identified
in only one to five screens may represent cases of interallelic
complementation (see below) or may define genes involved in
4778 Genetics: Bruno et al.
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Table 3. Representative ro mutants displaying unlinked noncomplementation
ro mutants displaying unlinked noncomplementationt
C.G. Defining allele* ro(A40) ro(B10) ro(C81) ro(D3) ro(E58)
1 ro-l(B15) - - - +
2 ro-2(B20) + + - + +
3 ro-3(R2354) - - - +
4 ro-4(P904) + + + - +
5 ro-7(P997) + + - +
6 ro-1O(AR7) - + + +
7 ro-l1(P3053) + + - + +
8 ro(B2) - +
9 ro(JT2) + + + + +
10 ro-l(A59) + - + +
11 ro(L12) + + + + +
12 ro(C52) + + + + +
13 ro(K51) + + - + +
14 ro(C18) + + + + +
15 ro(C102) + + + +
16 ro-3(C115) + + + + +
17 ro(C76) + + - + +
18 ro(U3) + + + + +
19 ro(1107) + + - - +
20 ro(J1) + + + + +
21 ro(G42) + + + + +
22 ro(P56) - + + +
23 ro(M76) + + + + +
Complementation analysis was conducted by pair-wise formation of heterokaryons. + and - signify complementation or
noncomplementation, respectively, based on whether a heterokaryon grows as straight, rapidly extending hyphae or grows as
curled hyphae, respectively. C.G., complementation group.
*Defining allele signifies the ro allele that was used as a tester strain to define a given complementation group.
tFive representative ro mutants out of a total of 121 ro mutants that fail to complement more than one of the ro tester strains.
multiple processes, only some ofwhich are cytoplasmic dynein-
dependent. For example, actin and CapZ, a barbed-end actin-
binding protein composed of a and 3subunits, are required for
many cellular processes, but they are also components of
dynactin (11). One would predict that rare complementation
groups may result from mutations in genes encoding CapZ
subunits or actin that disrupt the activity of dynactin without
adversely affecting dynactin-independent activities.
Interallelic complementation was observed for both ro-1 and
ro-3, which encode cytoplasmic dynein heavy chain and
pl5OGlued, respectively (Tables 1 and 2). Because cytoplasmic
dynein and dynactin contain two molecules of cytoplasmic
dynein heavy chain and pl5OGlued, a possible interpretation of
interallelic complementation is that a functional complex is
made by combining two defective Rol or Ro3 polypeptides. If
Rol and Ro3 consist of multiple, functionally independent
domains, then two mutant polypeptides, each defective in a
different domain, may combine to form a functional complex.
An attractive extension of this hypothesis is that given a
"sufficiently large" sample size of independent ro-1 and ro-3
mutants, a pair-wise complementation analysis of ro-1 and ro-3
mutants could allow the identification of all functionally
independent domains within Rol and Ro3 polypeptides. We
have initiated this study for ro-1 by conducting pair-wise
complementation tests using one ro-1 mutant from each of the
24 screens. Our initial results indicate that six combinations of
independent ro-1 mutants are capable of interallelic comple-
mentation (Table 2). It is not clear how many potential
functional domains are defined by these ro-1 mutants; how-
ever, ro-1 alleles A5, B10, and Eli and alleles C24, 039, and
V22 appear to loosely define two groups. One complication of
this analysis is that a mutation may disrupt more than one
functional domain and a large sample size of ro-1 mutants will
be needed to control for this effect.
We observed 121 ro mutants showing noncomplementation
with two or more ro mutants defining unlinked loci (Table 3).
An interesting characteristic of these ro mutants is that some
of them are allele-specific for noncomplementation with ro-1
and ro-3 mutants. ro(A40) does not complement the ro-l(B15)
or ro-3(R2354) testers, but it does complement the ro-l(A59)
and ro-3(C115) testers (Table 3). Three models for explaining
unlinked noncomplementation are the dosage model, the
poison-complex model, and the accumulated defects model
(for a more complete discussion, see refs. 22-24). In the dosage
model, formation of a diploid or a heterokaryon between an
A- and a B- strain, where gene product A and B interact and
are required for completion of a process, would result in
noncomplementation if the fraction of active A+/B+ complex
formed would be insufficient for completion of the process. In
the poison-complex model, the A-/B- complex formed in the
diploid/heterokaryotic strain is a "poison" that actively inter-
feres with the activity of the A+/B+ complex. In the accumu-
lated defects model, genes A and B define two independent
pathways that impinge on a single process. Reduced dosage of
functional A and B in an A+/A-; B+/B- diploid or hetero-
karyon results in a decrease in the efficiency of both indepen-
dent pathways and the generation of a mutant phenotype.
Some notable examples of unlinked, noncomplementing mu-
tants are S. cerevisiae mutants defective in a- and f3-tubulin
(22), S. cerevisiae mutants defective in actin and actin-binding
proteins (23), and Chlamydomonas mutants that are defective
in genes encoding subunits of axonemal outer arm dynein (24,
25).
The dosage, poison-complex, and accumulated defects mod-
els of unlinked noncomplementation suggest that the respec-
tive gene products either interact directly or define indepen-
dent pathways that are both required for successful completion
of a process. All 23 mutants defining the 23 complementation
groups are noncomplementing with one or more of the 121
mutants that show unlinked noncomplementation. Based on
the dosage and poison-complex models and the observation
that ro-1, ro-3, and ro-4 encode either dynein or dynactin
subunits, the genes defined by the 23 complementation groups
may encode proteins that are subunits of dynein/dynactin or
Genetics: Bruno et al.
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proteins that physically interact with the dynein/dynactin
complexes. The allele specificity of noncomplementation seen
for ro-l and ro-3 mutants (described above) is also consistent
with a physical-interaction model. However, nuclear move-
ment and nuclear distribution in filamentous fungi are likely to
require not only proper assembly and activity of cytoplasmic
dynein and dynactin complexes, but also the coordinated
activities of cytoplasmic dynein motors and components of the
cytoskeleton (5). As in the accumulated defects model, non-
complementation may in some cases result from reduced
activity of both motor and cytoskeletal "pathways." Finally, it
is important to recognize that complementation analysis in N.
crassa is conducted by the formation of heterokaryons and
variation in nuclear ratios and uneven mixing of ro gene
products may alter dosage and be contributing factors to
unlinked noncomplementation. Therefore, while allele-
specific, unlinked noncomplementation often is an indicator of
protein-protein interaction, caution is required in the inter-
pretation of noncomplementation among N. crassa ro mutants.
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